NCT04827472

Study to Evaluate the Safety/Tolerability, Pharmacokinetics, and Pharmacodynamics After Intravenous DWJ1521 Administration in Healthy Adult Volunteers

A Randomized, Double Blind, Placebo-controlled, Single Dose, Dose-escalation Study to Evaluate the Safety/Tolerability, Pharmacokinetics, and Pharmacodynamics After Intravenous DWJ1521 Administration in Healthy Adult Volunteers

• Status: Unknown
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 36 (estimated)
• Sponsor: Daewoong Pharmaceutical Co. LTD. · Industry
• Sex: All
• Age: 19 Years – 50 Years
• Healthy volunteers: Accepted

Summary

The safety/tolerability and pharmacokinetic properties of DWJ1521 are evaluated after single intravenous administration of DWJ1521 in healthy adults. The safety/tolerability and pharmacokinetic properties of DWJ1521 single intravenous administration and DWP14012 single oral administration in healthy adults are compared.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	Normal saline	100ml
DRUG	DWJ1521	Single dose
DRUG	DWP14012 Tablet	Single dose, Tablet

Timeline

• Start date: 2021-01-20
• Primary completion: 2021-06-30
• Completion: 2021-07-31
• First posted: 2021-04-01
• Last updated: 2021-06-10

Locations

1 site across 1 country: South Korea